PHARMACOECONOMICS

Scope & Guideline

Advancing understanding of drug costs and health outcomes.

Introduction

Delve into the academic richness of PHARMACOECONOMICS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1170-7690
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1992 to 2024
AbbreviationPHARMACOECONOMICS / Pharmacoeconomics
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The journal 'PHARMACOECONOMICS' focuses on the economic evaluation of health technologies, aiming to inform healthcare decision-making through rigorous analysis and modeling. It emphasizes the integration of clinical effectiveness with economic implications, encouraging a multidisciplinary approach that encompasses health policy, pharmacoeconomics, and public health.
  1. Economic Evaluation of Health Technologies:
    The journal publishes studies that evaluate the cost-effectiveness of various health interventions, including pharmaceuticals, medical devices, and healthcare services, using methodologies such as cost-utility analysis, cost-effectiveness analysis, and budget impact analysis.
  2. Modeling Approaches in Health Economics:
    A significant focus is on the development and application of various modeling techniques, including Markov models, discrete event simulation, and probabilistic modeling, to assess long-term outcomes and economic impacts of health interventions.
  3. Patient-Centered Outcomes and Quality of Life:
    Research related to the measurement of health-related quality of life (HRQoL) and patient preferences is prominent. This includes studies on utility measures like EQ-5D and their application in economic evaluations.
  4. Real-World Evidence and Data Utilization:
    The journal encourages the use of real-world data to inform economic evaluations and policy decisions, emphasizing the relevance of real-world evidence in assessing the economic impact of interventions.
  5. Interdisciplinary Approaches to Health Economics:
    It promotes an interdisciplinary perspective, integrating insights from clinical research, epidemiology, health policy, and behavioral economics to enhance the depth and applicability of economic evaluations.
The journal 'PHARMACOECONOMICS' is adapting to contemporary healthcare challenges and evolving research methodologies. Recent publications indicate a strong focus on innovative approaches and emerging themes in health economics.
  1. Value-Based Healthcare and Pricing Models:
    There is a growing emphasis on value-based healthcare frameworks that assess the value of interventions in terms of outcomes relative to costs. This trend reflects the shift towards outcome-oriented pricing models in the healthcare industry.
  2. Equity and Social Determinants of Health:
    Research addressing health equity and the social determinants of health is gaining traction, emphasizing the importance of considering how economic evaluations can impact diverse populations and promote equitable healthcare access.
  3. Integration of Real-World Data:
    The use of real-world data in economic evaluations is on the rise, highlighting the importance of incorporating actual patient outcomes and resource utilization into cost-effectiveness analyses.
  4. Patient and Stakeholder Engagement:
    There is an increasing focus on involving patients and stakeholders in the economic evaluation process to better capture preferences and improve the relevance of health technologies to end-users.
  5. Innovative Methodological Approaches:
    Emerging methodologies, such as machine learning and advanced statistical techniques, are being applied to economic evaluations, enhancing the robustness and precision of analyses in complex healthcare environments.

Declining or Waning

While the journal continues to thrive in various areas, certain themes have shown a decline in prominence over recent years. This shift may reflect changing priorities in health economics and emerging challenges in the healthcare landscape.
  1. Traditional Cost-Effectiveness Analysis:
    There is a noticeable reduction in studies solely focused on traditional cost-effectiveness analysis without considering broader implications, such as equity or long-term societal impacts. This indicates a shift towards more comprehensive evaluation frameworks.
  2. Pharmacoeconomic Evaluations of Older Therapies:
    Research on older therapies appears to be declining as newer, more innovative treatments emerge. The focus is shifting towards assessing the economic impact of cutting-edge therapies and technologies rather than established treatments.
  3. Narrowly Focused Economic Models:
    The journal has seen fewer publications that rely on narrowly focused economic models with limited scope. There is now a trend towards more complex models that account for a variety of factors, including patient heterogeneity and real-world complexities.
  4. Sole Emphasis on Cost Minimization:
    Papers that primarily focus on cost minimization strategies without addressing the broader implications for health outcomes and quality of life are becoming less frequent, as the field moves towards more holistic evaluations.
  5. Regional Studies with Limited Generalizability:
    There is a waning interest in studies that focus exclusively on localized economic evaluations without consideration for broader applicability or generalizability to other settings or populations.

Similar Journals

HEALTH SERVICES RESEARCH

Advancing health policy through rigorous research.
Publisher: WILEYISSN: 0017-9124Frequency: 6 issues/year

HEALTH SERVICES RESEARCH, published by Wiley, is a premier journal focused on advancing the field of health policy and services research. With an ISSN of 0017-9124 and an impressive E-ISSN of 1475-6773, this esteemed publication has been at the forefront of health services inquiry since its inception in 1966. Recognized as a Q1 journal in Health Policy for 2023, it ranks #80 out of 310 in Scopus, placing it in the 74th percentile, underlining its significant influence in the field. The journal caters to a global audience of researchers, practitioners, and students by providing a platform for rigorous empirical studies and critical reviews that aim to improve health care delivery and policy outcomes. Although it does not offer open access, the comprehensive articles and insights published within its pages are essential for anyone seeking to understand and influence health systems. With its convergence towards the year 2024, HEALTH SERVICES RESEARCH continues to be a vital resource for those dedicated to enhancing healthcare effectiveness and accessibility.

Journal of the American College of Clinical Pharmacy

Fostering collaboration in the pursuit of pharmaceutical advancements.
Publisher: WILEYISSN: Frequency: 6 issues/year

Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.

JOURNAL OF HEALTH ECONOMICS

Shaping the Future of Health Care with Economic Insights
Publisher: ELSEVIERISSN: 0167-6296Frequency: 6 issues/year

JOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.

Farmeconomia-Health Economics and Therapeutic Pathways

Driving the future of health economics with open access knowledge.
Publisher: SEED MEDICAL PUBLISHERSISSN: 1721-6915Frequency: 1 issue/year

Farmeconomia-Health Economics and Therapeutic Pathways is a pioneering journal within the field of health economics, dedicated to exploring the intersections of health policy, therapeutics, and economic evaluations. Published by SEED MEDICAL PUBLISHERS, this Open Access journal has been at the forefront of advancing knowledge since 2012, ensuring that vital research is readily accessible to a global audience without subscription barriers. The journal aims to facilitate the dissemination of insightful studies, systematic reviews, and theoretical discussions that determine the cost-effectiveness of therapeutic options, ultimately guiding evidence-based healthcare decisions. Based in *Torino, Italy*, this journal is committed to serving researchers, healthcare professionals, and students who are eager to contribute to and stay updated on the latest developments in health economics and policy implementation. With its broad-ranging scope and dedication to quality research, Farmeconomia stands as an essential resource for anyone engaged in the complex dynamics of health systems and their economic implications.

Journal of the National Comprehensive Cancer Network

Empowering Researchers: Your Source for Cutting-Edge Cancer Discoveries
Publisher: HARBORSIDE PRESSISSN: 1540-1405Frequency: 15 issues/year

The Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.

Exploratory Research in Clinical and Social Pharmacy

Fostering collaboration in the evolving pharmacy landscape.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

Pharmacoeconomics-Open

Empowering Healthcare Decisions Through Open Research
Publisher: SPRINGER INT PUBL AGISSN: 2509-4262Frequency: 4 issues/year

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

ADVANCES IN THERAPY

Elevating medical research to new heights.
Publisher: SPRINGERISSN: 0741-238XFrequency: 12 issues/year

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

VALUE IN HEALTH

Empowering Decision-Makers with Cutting-Edge Health Research
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

International Journal of Healthcare Management

Empowering healthcare leaders with cutting-edge insights.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2047-9700Frequency: 4 issues/year

The International Journal of Healthcare Management, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, stands as a crucial platform for the dissemination of innovative research and insights in the realm of healthcare management. With a focus on health policy, leadership, and management, this journal aims to bridge the gap between theory and practice, providing a valuable resource for researchers, professionals, and students alike. It boasts an impressive Q2 ranking in Leadership and Management and a Q3 ranking in Health Policy for 2023, highlighting its influence and relevance within the academic community. With an accessible ISSN of 2047-9700 and E-ISSN of 2047-9719, the journal features an array of peer-reviewed articles that promote the advancement of knowledge and best practices in healthcare settings. While currently not offered as open access, the journal publishes high-quality research that underscores the importance of effective management strategies in enhancing healthcare outcomes. Positioned in the United Kingdom, the journal continues to contribute significant knowledge and frameworks that guide healthcare leaders and policymakers in navigating the complexities of governance in health services.